Pyramid Bio

Quiver Bioscience, formerly known as Q-State Biosciences, is a leading biotechnology company based in Cambridge, MA, dedicated to revolutionizing drug development for neurological diseases. With a decade of scientific advancements and cutting-edge technology, Quiver utilizes human disease models, artificial intelligence, and a state-of-the-art platform to discover and develop transformative medicines for patients living with brain disorders. Driven by their innovative approach, Quiver integrates scalable biology, advanced engineering, and surrogate models to identify novel therapeutic targets and candidate molecules. Their proprietary cellular models capture the complexities of human biology, while their lineup of technologies and instrumentation measures hundreds of properties associated with cellular function per neuron. Through their analytics algorithms, Quiver extracts data from individual cells to gain insights into disease states and optimize therapeutic candidates with greater translational potential.Generated from the website

Emulate Inc, based in Boston, MA, offers a cutting-edge platform for modeling the holistic journey of solid tumor cell therapy through organ chips. Their innovative technology allows researchers to simulate key processes such as vascular administration, endothelial attachment, T cell migration, and antigen-specific killing in a vascularized cancer cell line model. With a focus on reducing translational failure and improving human disease research, Emulate's human emulation system provides unparalleled insights into the inner workings of human biology. Their platform, comprised of instruments, consumables, and software, is user-friendly and flexible, offering researchers a powerful tool for advancing research and drug development in various fields such as cancer gene therapy, immunology, infectious disease, and neuroscience. Generated from the website

Cell Signaling Technologies, based in Beverly, MA, is recognized globally for its extensive range of high-quality antibodies and related research products, serving the life sciences community for over 25 years. The company's product offerings include primary and secondary antibodies, ELISA kits, cellular assay kits, and an array of reagents and comprehensive solutions tailored for various applications including cancer research, immunology, and neuroscience. With a commitment to reliability and validation, Cell Signaling Technologies provides leading-edge solutions for research through robust assay platforms and continuous supply of essential products. Their dedication to environmental and social responsibility further underscores their role as a trusted partner in advancing scientific discovery. Generated from the website